Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital health technologies
Abstract The US Food and Drug Administration (FDA) has publicly recognized the importance of improving drug development efficiency, deeming translational biomarkers a top priority. The use of imaging biomarkers has been associated with increased rates of drug approvals. An appropriate level of valid...
Saved in:
Main Authors: | Elena S. Izmailova (Author), R. Paul Maguire (Author), Timothy J. McCarthy (Author), Martijn L. T. M. Müller (Author), Philip Murphy (Author), Diane Stephenson (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Digital health technology derived measures: Biomarkers or clinical outcome assessments?
by: Elena S. Izmailova, et al.
Published: (2023) -
Digital technologies: Innovations that transform the face of drug development
by: Elena S. Izmailova, et al.
Published: (2023) -
Advancing autonomy in Tunisian higher education: Exploring the role of technology in empowering learners
by: Mimoun Melliti, et al.
Published: (2024) -
Empowering the teacher through cloud technologies
by: V. O. Udovenko
Published: (2013) -
Fit‐for‐Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker Experience
by: Alan Godfrey, et al.
Published: (2021)